Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 3 20Phase 2/3 7Phase 1/2 5Phase 1 4Phase 4 3Phase NA 2

Status

Completed 12Unknown 7Not yet recruiting 3Terminated 2Recruiting 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Endocrine 1

Conditions

Colorectal Neoplasms 2Neoplasm Metastasis 1Carcinoma, Neuroendocrine 1

Interventions

anlotinib 5Cisplatin 5Carboplatin 5Immune Checkpoint Inhibitors 4tislelizumab 3sintilimab 3lenvatinib 3Oxaliplatin 3Fluorouracil 3Capecitabine 3Bevacizumab 3venetoclax 2Rosuvastatin Calcium 2Prednisone 2Megestrol Acetate 2Leucovorin 2Gemcitabine 2Drug Therapy 2Dexmedetomidine 2Dexamethasone 2Aspirin 2zanubrutinib 1xiaojin wan 1trastuzumab deruxtecan 1trametinib 1toripalimab 1tocilizumab 1testosterone 17 beta-cypionate 1tenofovir alafenamide 1telitacicept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Not yet recruiting × Fluorouracil × Clear all
NCT07446465 2026-03-03

FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer

Fudan University

Phase 4 Not yet recruiting
42 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT07094893 2026-01-14

ARIEL-ENGIC

Gruppo Oncologico del Nord-Ovest

Phase 4 Not yet recruiting
280 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07014540 2025-06-11

A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma

Beijing GoBroad Hospital

Phase 4 Not yet recruiting
45 enrolled
Endocrine

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡